OBJECTIVES: Frailty syndrome predicts adverse outcomes after surgical aortic valve replacement. However, disability or comorbidity is frequently associated with preoperative frailty evaluation. The effects of these domains on early and late outcomes were analysed.
Frailty, disability and comorbidity: different domains lead to different effects after surgical aortic valve replacement in elderly patients 
INTRODUCTION
Severe aortic stenosis (SAS) is a condition with a pooled 3.4% prevalence among patients >75 years old [1] , making this entity relevant enough to be considered a public-health issue. Once symptoms of aortic stenosis are developed, prognosis is severely affected [2] . Surgery has demonstrated the ability to restore life expectancy [3] and constitutes a class I indication for symptomatic aortic stenosis [4] . However, a significant proportion of elderly patients are not referred for surgical aortic valve replacement (SAVR) [5] . The advent of transcatheter aortic valve implantation (TAVI) increased the interest in determining which patients could not benefit from the surgical approach. A short-term mortality risk stratification can be performed using the European System for Cardiac Operative Risk Evaluation (EuroSCORE) and the Society of Thoracic Surgeons (STS) Adult Cardiac Surgery Risk Calculator. These scores adequately discriminate high-risk patients but their calibration has been questioned [6] . Frailty is a geriatric syndrome characterized by increased vulnerability, impaired resilience and reduced ability to recover from even minor stressors due to ageing-related decline in multiple physiological systems [7, 8] . Frailty, disability and other comorbidities are underlying factors in varying health outcomes in older patients that are not accounted for by traditional risk scores. Therefore, these factors should be integrated in risk assessment to better identify patients at increased risk of cardiac surgery. However, no consensus has been achieved on how to best diagnose this vulnerability.
Fried et al. [9] hypothesized that frailty, disability and comorbidity are different domains, but some authors included components of disability that were not validated in frailty assessment questionnaires.
Afilalo et al. [10] demonstrated an association between gait speed and worsened operative outcomes after SAVR. Nevertheless, multicomponent frailty evaluations provide better risk discrimination [11] and improve prediction [12] .
We hypothesized that frailty, disability and advanced comorbidity are different entities, which contribute to surgical risk. Therefore, we aimed to compare whether these 3 domains show different prognostic associations with patient outcomes.
METHODS

Study design and participants
This is a prospective observational cohort study that included patients > _75 years old with symptomatic SAS who underwent SAVR with or without concomitant coronary artery bypass grafting (CABG) between 1 February 2010 and 30 January 2015. Methods have been previously described for the general SAS patient cohort and here we include and specify the methods for patients who received SAVR [8] . Treatment selection was agreed on by the local heart team that included a cardiac surgeon, anaesthetist, geriatrician and interventional and clinical cardiologists.
Five inclusion criteria were considered: (i) age of 75 years or older; (ii) echocardiography data of SAS; (iii) symptoms potentially attributable to SAS, such as effort dyspnoea, angina or syncope; (iv) patients received comprehensive geriatric assessment that included frailty, disability and comorbidity evaluation; and (v) the patient's case was discussed at the heart team meeting and SAVR was agreed as the advised treatment. Non-elective cases were excluded. The sample size was determined by the aforementioned period of time, during which the patients who met the inclusion criteria were consecutively enrolled.
This study was conducted in accordance with the 2000 Helsinki ethics statement. All patients gave written informed consent to participate and the local institutional and ethics committee approved the study protocol. It was registered at clinicaltrials.gov (NCT02745314).
Study variables
We recorded sociodemographic and biomedical variables from the comprehensive geriatric assessment.
Sociodemographic variables included age, sex, educational level and cohabitation. Biomedical variables included the following: (i) anthropometric variables: height, weight, body mass index and body surface area; (ii) comorbidities, with the Charlson comorbidity index (CCI) as a summary indicator [13] ; (iii) the STS-PROM and logistic EuroSCORE surgical risk scores; (iv) echocardiographic data: left ventricle ejection fraction, aortic valve area, transvalvular peak velocity and medium aortic transvalvular gradient; (v) New York Heart Association functional class; and (vi) laboratory determinations: N-terminal pro BNP peptide (NTproBNP), haemoglobin, erythrocyte sedimentation rate and estimated glomerular filtration rate, as estimated with the Modified Diet in Renal Disease formula. Renal failure was defined as an estimated glomerular filtration rate below 60 ml/min or serum creatinine >1.2 mg/dl in a steady state.
Frailty, disability and comorbidity assessment
Patients were primarily classified according to the Cardiovascular Health Study (CHS) frailty phenotype proposed by Fried et al. comprising 5 components: (i) low grip strength; (ii) slowness; (iii) low physical activity, as assessed with the Physical Activity Scale for the Elderly (PASE) questionnaire; (iv) exhaustion, based on the Centre for Epidemiologic Studies Depression Scale; and (v) unintentional weight loss. A patient was considered frail if he or she met 3 or more of the above criteria, pre-frail when 1 or 2 criteria were met and robust when no criterion was met. For this analysis, robust and pre-frail patients were grouped as non-frail.
Dependence and comorbidity were also evaluated as covariates. Disability was assessed by dependence on instrumental activities of daily living (IADL) according to the Lawton-Brody index [14] . Any loss in IADL was considered valuable because it preceded basic deficits. Lawton-Brody index was considered significant if the score was < _4 for men or < _7 for women. To evaluate comorbidity, we used CCI as a dichotomous item, classifying patients into 2 groups according to the presence or absence of severe comorbidities (CCI > _ 4).
Outcomes
The main outcome was perioperative (30-day), 1-year and 3-year mortalities. Vital status was assessed for follow-up through 15 December 2016. This follow-up was performed at periodical outpatient clinic visits, by checking the electronic medical records, including primary care visits, or by telephone contact with patients or their relatives. We also analysed postoperative cardiac output, red blood transfusion, critical care length of stay and global postoperative length of stay as secondary outcomes.
Statistical analysis
Categorical variables are expressed as frequencies (%) and univariable associations were tested using the v 2 or Fisher's exact test. Continuous variables are expressed as mean ± standard deviation or median-interquartile range (IQR), and the Student's t-test was used to analyse univariable differences. Frailty, disability and multiple comorbidities were examined as dichotomous variables. The univariable association between baseline variables and mortality was analysed using Cox regression. Frailty phenotype, disability, multiple comorbidities and the variables associated with mortality (P < 0.05) on univariable analysis were selected for a multivariable analysis using Cox regression models with backwards stepwise elimination to identify variables independently associated with mortality. Specific analyses were repeated after censoring patients at 1 and 3 years of follow-up. Follow-up duration was calculated after censoring patients at the time of the event or at the end of the follow-up (for patients without events). Results are summarized with hazard ratios (HR) and their 95% confidence interval (CI). Event-free survival was calculated by the Kaplan-Meier method. P-values <0.05 were considered statistically significant.
The software SPSS Statistics version 20 (IBM SPSS v20.0, IBM Corp.) was used to conduct all statistical analyses.
RESULTS
Among the 183 included patients, 57 (31%) were frail and 126 (69%) were non-frail. The mean age was 80.8 ± 3.6 years and 50% were women. There were no differences between frail and non-frail patients in sociodemographic characteristics or cardiovascular risk factors, although diabetes mellitus was more frequent among frail individuals (Table 1) . Anaemia, peripheral vascular disease, collagenosis, neoplasia, depression and fractures were significantly more frequent in frail individuals (Table 1) . Frail patients also showed a higher prevalence of dependence in IADLs, lower scores in cognitive tests, worse quality of life and higher levels of comorbidities as measured by CCI. STS-PROM scores were similar between the groups, but the logistic EuroSCORE was significantly higher in frail patients (Table 1) . No differences were observed in baseline echocardiographic variables (Table 1) , complexity of procedures or cardiopulmonary bypass/cross-clamp time.
Follow-up was completed for all patients with a median (IQR) of 869 (699-1099) days. Postoperative 30-day, 1-year and 3-year mortality rates were 1.6%, 6.6% and 9.8%, respectively.
Among the deceased patients, 67% were frail (P < 0.01), 33% showed dependence in IADL (P < 0.01) and 83% scored 4 or more in CCI (P < 0.01).
Cumulative 1-year Kaplan-Meier survival analysis showed significantly increased mortality in frail patients compared with non-frail counterparts (14.0% vs 3.2%; P = 0.006) (Fig. 1) .
Three-year Kaplan-Meier survival analysis showed marginally significant differences of mortality in frail versus non-frail patients (15.8% vs 7.1%; P = 0.049), significantly increased mortality in IADL dependent versus independent patients (28.8% vs 7.9%; P = 0.005) (Fig. 2 ) and for those with CCI > _4 vs CCI <4 (17.9% vs 5.2%; P = 0.005) (Fig. 3) .
On univariable analysis, factors related with 30-day mortality were CCI > _4 (100% in patients who died; P = 0.048), STS-PROM (9.5 ± 3.2 in deceased patients vs 4.8 ± 3.6 in survivors; P = 0.024), peripheral vascular disease (66.7% prevalence in deceased patients vs 7.8% in survivors; P = 0.021) and chronic renal failure (66.7% prevalence in deceased patients vs 12.8% in survivors; P = 0.049). CCI, concomitant CABG and low ejection fraction were risk factors for postoperative low cardiac output (P < 0.05). Forty-five percent of patients did not receive any perioperative red blood cells and no differences in transfusion rate were found regarding frailty or disability. Advanced comorbidity (CCI > _ 4) was associated with more red blood cell transfusion, longer critical care unit stay and postoperative hospital stay (P < 0.05).
Peripheral vascular disease, preoperative atrial fibrillation, chronic renal failure, diabetes, CCI, CCI > _4, STS-PROM, logistic EuroSCORE, dependence IADL, frailty and quality of life were found to be significantly related with 1-year mortality in the univariable analysis (Table 2 ). According to the multivariable Cox regression analysis, preoperative atrial fibrillation, CCI > _4 and frailty were significantly related with 1-year mortality (Table 2 ).
In the 3-year mortality multivariable analysis, preoperative disability in IADL, CCI > _4 and preoperative atrial fibrillation were independent predictors, but frailty was not (HR 1.49, 95% CI 0.51-4.36; P = 0.47) ( Table 2 ).
DISCUSSION
Our study shows that in older patients who receive SAVR treatment for symptomatic SAS, frailty phenotype is a risk factor for mortality from hospital discharge over the first year postoperatively; disability in IADL is a long-term predictor of mortality and advanced comorbidity is a risk factor for mortality at any time after the procedure. Reported prevalence of frailty among surgical populations is very variable (7-70%) due to the heterogeneity of tools used [11] . In our study, frail patients represented 31% of the whole cohort, which is higher than 23% prevalence reported by Ad et al. [15] , potentially influenced by the higher mean age of our patients (80.8 ± 3.6 years vs 74.1 ± 6.6 years). We also present data for a follow-up duration to estimate the relationship of frailty and disability with SAVR outcomes, which were not previously reported [15] [16] [17] [18] .
The frailty tool we used is based on the concept that frailty, disability and comorbidity are different domains, so varying assessments tools were used [9] . Our study of older old patients receiving SAVR provides short-, medium-and long-term results.
Context of the study and definitions adopted
In 2001, Gardner et al. [19] pointed to non-cardiac variables as important predictors for medium-term mortality after CABG, whereas most short-term risk factors were cardiac-related variables. Lee et al. [16] for the first time reported in 2010 an association between frailty and cardiac surgery outcomes. The frailty definition they used included dependence in IADL and cognitive impairment. An important implication of defining a proper tool for frailty evaluation was the individualized treatment selection.
Several studies found a statistically significant association of frailty with adverse outcomes after cardiac procedures, surgical or transcatheter [10, 16, 20, 21] . Afilalo et al. [10] described that slowness, defined as a time > _6 s to walk 5 m with a normal gait, was an independent predictor for morbidity and mortality in patients > _70 years old undergoing cardiac surgery. They found that STS score prediction of mortality was improved with the inclusion of gait speed. Nevertheless, some authors consider that gait speed could be more useful in risk assessment when used as part of a multidimensional assessment because multicomponent frailty instruments show better prediction than single-component tools [15, 17, 22] . Dependence, as part of a multidimensional geriatric assessment, has been associated with adverse outcomes after SAVR [17] or TAVI [23] , but no data exist regarding specific evaluation of IADL dependence and late results in a cardiac surgery population. In line with Stortecky et al.'s [23] findings in TAVI patients, inability to perform IADL was not significantly associated with outcomes at 30 days or 1 year in our study, but was a risk factor for 3-year mortality.
Comorbidity rated by the CCI has been a predictive tool of postoperative events in non-cardiac surgery, SAVR [24] and TAVI [25] . It is a validated index that can even be adapted by the International Classification of Diseases codes to improve transferability [26] .
Operative outcome
We show that a proper selection of patients enabled us to carry out the procedure with good perioperative results in these aged patients. Observed operative mortality was low (1.6%), in the range of recent data reported by other authors [27] . After adjustment, frailty was not a risk factor for operative mortality as Ad et al. [15] reported. We found a non-significant trend to worsened early outcomes, including perioperative transfusion, longer critical care unit stay, critical care unit readmission or hospital length of stay among frail and patients with disabilities for IADLs, that could have been affected by the low frailty burden in our sample, the sample size and favourable cardiac conditions such as a mean ejection fraction of 57.0 ± 10.7% and 1.1% of patients with moderate or more aortic regurgitation. Afilalo et al. [10] and Lee et al. [16] linked frailty to operative morbidity and mortality, but the latter study included dependence in their definition.
One-year outcome
In a systematic review, Kim et al. [11] identified 8 studies reporting association between preoperative frailty and surgical outcomes beyond 6 months [15] [16] [17] [18] [19] . However, only Ad et al. [15] used CHS Frailty Phenotype assessment tool in SAVR and Muñoz-García and Ewe in TAVI [20, 28] . For the follow-up after SAVR, frailty was an independent predictor for mortality in every study [16] [17] [18] but not in the study of Ad et al. [15] . Despite we found few mortality events in our patients, frailty was associated with a 3.4-fold increased risk for 1-year mortality.
Three-year outcome
Our analysis showed that preoperative severe comorbidities and IADL disability were associated with lower 36-month survival. Long-term mortality was also associated with increasing comorbidities and preoperative atrial fibrillation at 12 and 36 months. In line with these results, Martinez-Selles et al. [29] and Kearney et al. [24] found that a high CCI is associated with increased mortality. Of note, frailty was not predictive of mortality after 12 months.
On multivariable analysis, preoperative IADL-dependence was not significantly related to 1-year mortality as it was the case at 3-year follow up, despite the fact that we found a significant increase of mortality at 1-year follow-up on univariable analysisKaplan-Meier curves (Fig. 2) . Lee et al. [16] , who included disability as a measure for frailty, found an association with mortality at 22 months.
Frailty is a potentially reversible vulnerability condition, which extends functional recovery time after a stressor; however, disability is a permanent condition, which influenced the long-term results in our series. Given that frailty is considered a predisability reversible state, our findings lead to make efforts to achieve recovery of the functional condition with rehabilitation, nutritional support and treatment optimization of comorbidities that could potentially improve the survival of frail elderly patients submitted to SAVR.
We also found a relevant role of preoperative atrial fibrillation as a prognostic factor at 1-and 3-year follow-up. Atrial fibrillation is a well-known independent risk factor for mortality after SAVR [30] due to the higher rate of thromboembolic and haemorrhagic complications, more prevalence of heart failure and dysregulation of heart rate at rest or during exercise.
Study limitations and strengths
Our study has some limitations. First, since frailty should be assessed in clinically stable patients, individuals who underwent operations during a hospital admission due to an acute condition were not included in the study, and frailty prevalence could have been affected. However, patients are mainly referred to surgery on an elective basis; consequently, our results are unlikely to be modified. Second, the CHS Frailty Phenotype is a dichotomous variable, severity of frailty could not be graded and classification in categories of frailty could be better related to SAVR outcomes. Third, the cut-off points for the criteria used in CHS Frailty Phenotype were validated in a North-American population that could have overestimated frailty prevalence in our cohort. Fourth, frailty was assessed on recruitment, and given that it is a condition that can change over time, variations in frailty state from assessment to intervention cannot be excluded. Fifth, this is a selected cohort of patients who received heart team-oriented treatment and consequently with a low rate of frailty and an average intermediate risk that could have made prognosis better and lower the likelihood of mortality. However, the findings attributable to a frailty condition can be extended to other frail patients. Sixth, we could not recover the long-term cause of death beyond perioperative mortality, and this could be relevant to disclose the interaction between the cardiac condition and comorbidities in patients' outcome. Finally, cohort size (n = 183) could compromise statistical power and might have not allowed to find association between frailty and some morbidity items or even operative mortality.
Otherwise, this study is supported by some strengths. It is a prospective study, which demonstrates that excellent results can be achieved by using a multidisciplinary heart team patient assessment, with involvement of an expert geriatrician. Finally, frailty and functional status were assessed with validated and widely used instruments that are appropriate for a busy clinical practice.
CONCLUSIONS
In patients aged > _75 years who receive SAVR for symptomatic SAS, frailty is a potentially reversible condition that is associated with mortality up to 1 year after surgical intervention. Operativeincreased mortality in frail patients is prolonged beyond 30 days. From the first year after SAVR, frailty seems not to be a risk factor for mortality, but disability is a permanent condition associated with long-term outcomes. Advanced comorbidity increases mortality after SAVR in the elderly at any time.
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